Labcorp Perspectives: Optimizing biomarker testing in advanced NSCLC: Insights on comprehensive genomic profiling (CGP)

In the latest episode of Labcorp Perspectives: Oncology, Dr. Rebecca Ann Previs and Dr. Kyle Strickland, directors of medical affairs at Labcorp Oncology, delve into the significant advantages of comprehensive genomic profiling (CGP) over single-gene testing in patients with advanced non-small cell lung cancer (NSCLC). This study, using OmniSeq® INSIGHT, showed that CGP enables that patients with NSCLC to be tested for all recommended biomarkers at once, providing the best chance of identifying effective treatment options.

Labcorp Perspectives: Oncology | Innovations in oncology: Highlights from ASCO's annual meeting (Episode 3)

The latest episode of Labcorp Perspectives: Oncology featuring Dr. Rebecca Previs, director of medical affairs at Labcorp Oncology, and Dr. Eric Severson, executive director of medical affairs at Labcorp, share notable insights from the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. They explore the role of liquid biopsies in cancer diagnostics, specifically Labcorp's Plasma Complete™ test, a noninvasive alternative to traditional biopsies.

Labcorp Perspectives: Oncology | How can HRD testing help patients with ovarian cancer? (Episode 2)

Presented by:

Dr. Rebecca Previs, MD, Director of Medical Affairs at Labcorp

Dr. Alison Roos, PhD, Associate Director of Medical Affairs at Illumina

Labcorp Perspectives - Oncology: Understanding an inflamed tumor microenvironment and how to leverage it for targeted therapy(Episode 1)